Menopause News and Research

RSS
Conference to discuss latest research on gender disparities in cardiovascular disease

Conference to discuss latest research on gender disparities in cardiovascular disease

Dried plums can protect postmenopausal women against fractures, osteoporosis

Dried plums can protect postmenopausal women against fractures, osteoporosis

Enrollment commences in RegeneRx RGN-259 Phase 2 trial for dry eye syndrome

Enrollment commences in RegeneRx RGN-259 Phase 2 trial for dry eye syndrome

Female sex hormone oestrogen could fight against cardiovascular disease

Female sex hormone oestrogen could fight against cardiovascular disease

PUFA intake linked to reduced risk of heart failure, kidney disease and preterm delivery

PUFA intake linked to reduced risk of heart failure, kidney disease and preterm delivery

Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis

Current Medical Research & Opinion publishes new data on EVISTA for postmenopausal osteoporosis

Test for ticking biological clock

Test for ticking biological clock

Soy useless for menopause

Soy useless for menopause

Positive results from Antares Pharma VIBEX MTX clinical study on RA

Positive results from Antares Pharma VIBEX MTX clinical study on RA

Conference to discuss novel studies that address how inherited genes cause breast cancer

Conference to discuss novel studies that address how inherited genes cause breast cancer

Prolonged estrogen deprivation reduces ability to prevent strokes

Prolonged estrogen deprivation reduces ability to prevent strokes

New BistroMD blog can help people lose weight

New BistroMD blog can help people lose weight

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

Menopause has no additional effect on risk for diabetes

Menopause has no additional effect on risk for diabetes

BioSante second quarter net loss increases to $15.0 million

BioSante second quarter net loss increases to $15.0 million

Fragile X syndrome study to reveal more

Fragile X syndrome study to reveal more

Bionovo completes 13 weeks repeat dose animal toxicology studies for Menerba

Bionovo completes 13 weeks repeat dose animal toxicology studies for Menerba

BioSante announces worldwide license of Melanoma Vaccine to Hussman Foundation

BioSante announces worldwide license of Melanoma Vaccine to Hussman Foundation

Novel approach to prevent ‘chemo’ induced menopause in breast cancer patients

Novel approach to prevent ‘chemo’ induced menopause in breast cancer patients

Study reveals how alcohol and weight influence breast cancer hormone levels in post menopausal women

Study reveals how alcohol and weight influence breast cancer hormone levels in post menopausal women

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.